Shield Therapeutics plc (STX) Earnings Call Transcripts

Shield Therapeutics plc's Latest Earnings Call - Q4 FY2026

In the fiscal fourth quarter of 2026, Seagate Technology reported robust financial results, with revenue of $3.6 billion, up 48% year-over-year, and non-GAAP EPS of $5.71, reflecting a 121% increase from the previous year. The company exceeded guidance on both revenue and earnings, driven by strong demand from cloud customers and the successful ramp-up of its HAMR technology. Management projects continued growth into fiscal 2027, expecting revenue to reach approximately $4.1 billion in the September quarter, indicating a year-over-year growth of 56%.

Reported metrics

Guidance from management

Management expects revenue for Q1 FY 2027 to be in the range of $4.1 billion, plus or minus $100 million, with non-GAAP EPS projected at $7.30, plus or minus $0.20. This guidance indicates continued growth and profitability expansion.

What management said

Aaron, I'll let Gianluca answer this quantitatively, but the way we're thinking about these product transitions is and I think you know this well, we have to actually put our factories on pause to go through the product and transition a little bit. So as we're moving product from 3 terabytes to 4 terabytes to 5 terabytes. And then there's yield issues. And as we out-execute our plan, what happens is we have opportuni...

Sorry, one more thing on that point because I think a lot of people still don't understand this. So the thing that's actually driving factory complexity is not just drive numbers or heads numbers or media numbers. It's actually the product transitions. These new products, say, 4 terabytes going to 5 terabytes, there will be more time in the tools, more time through the tools. Sometimes it has to touch the tool multip...

What analysts pressed on

Analysts expressed concerns about the sustainability of pricing growth and the impact of transitioning to higher capacity drives on margins. There were questions regarding how the demand for new applications, particularly in AI, would affect future exabyte growth.

Main topics on the call

• Revenue Growth Acceleration — Seagate achieved a revenue of $3.6 billion in Q4 2026, which was a 48% increase year-over-year and exceeded guidance. Management stated, "Given our momentum and the improved visibility we have into demand, we expect fisc...
• Strong Margin Expansion — Non-GAAP gross margin expanded to 52.7%, up 570 basis points sequentially, while non-GAAP operating margin increased to 44.6%. Management noted, "We achieved record profitability levels across gross margin, operating mar...
• HAMR Technology Adoption — Management reported that HAMR-based products represented approximately 40% of nearline exabyte shipments, with expectations to ramp to 50% by the end of calendar 2026. They emphasized that "our technology roadmap plays a...
• Free Cash Flow Generation — Seagate generated over $1.1 billion in free cash flow during Q4, marking the strongest quarter in over a decade. This was attributed to disciplined operational execution and strong demand, with management stating, "We ex...

Read the full Shield Therapeutics plc transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 85 Shield Therapeutics plc earnings call transcripts on record, spanning February 4, 2020 to July 30, 2026. Based on this history, Shield Therapeutics plc reports quarterly. The most recent call on file is dated July 30, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

STX

Exchange

AIM

Country

GB

Sector

Health Care

Industry

Pharmaceuticals

Calls on record

85

First call

February 4, 2020

Most recent

July 30, 2026

Reporting cadence

quarterly